课题基金 / 基金详情

PRICE 2: A phase 3 randomized controlled trial of phlebotomy resulting in controlled hypovolemia to prevent blood loss in major hepatic resections

PRICE 2: A phase 3 randomized controlled trial of phlebotomy resulting in controlled hypovolemia to prevent blood loss in major hepatic resections
PRICE 2:一项 3 期放血随机对照试验,导致控制性低血容量,以防止主要肝切除术中的失血
批准号:
372703
负责人:
Martel Guillaume
金额:
$36.22万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2017
资助国家:
加拿大
项目状态:
已结题
起止时间:
2017-09-01 至 2021-09-01

项目摘要

项目成果

Martel Guillaume的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The need for major liver surgery is growing rapidly. Despite improvements in techniques, these operations continue to carry a significant risk of hemorrhage and blood transfusion. Hypovolemic phlebotomy represents a simple, cheap, safe, and underreported
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Delphi survey to generate consensus among international experts on elements of an intraoperative transfusion protocol
  • 批准号:
    463049
  • 项目类别:
    Operating Grants
  • 资助金额:
    $5.29万
  • 财政年份:
    2022
  • 负责人:
    Martel Guillaume
  • 依托单位:
A Delphi survey to generate consensus among international experts on elements of an intraoperative transfusion protocol
  • 批准号:
    460778
  • 项目类别:
    Miscellaneous Programs
  • 资助金额:
    $1.09万
  • 财政年份:
    2022
  • 负责人:
    Martel Guillaume
  • 依托单位:
DRAGON 2 - An international multicenter randomized controlled trial to compare combined Portal and Hepatic Vein Embolization (PVE/HVE) with PVE alone in liver surgery
  • 批准号:
    463216
  • 项目类别:
    Operating Grants
  • 资助金额:
    $46.83万
  • 财政年份:
    2022
  • 负责人:
    Martel Guillaume
  • 依托单位:
海外基金